Over the last few days we have had some visitors. My great niece visited for a day and my friends Pody and Rick from Illinois. It was great to have them here.
But now I am ready to get back to "normal" if there is such a thing anymore. All of our company for the summer has come and gone and we don't really have much planned until we head out to Seattle to catch up with our son for a week's vacation. I think I am ready for some down time. I don't really realized until after the fact how tired I can get. It takes me a lot longer to get back to my routine. For a few days I will notice some problems with my Alzheimer's and have many more "Alzheimer's moments" but we have come to expect them and can live with them. We always have little "surprises" but nothing we can't deal with.
Lots of things are happening on the Alzheimer's research lately. Some scientists in Australia claim they have found a "cure" . The following is a quote from a recent article that was published in Ireland --
Scientists in Australia have developed a once-a-day pill, which they claim may cure Alzheimer's disease. Human trials of the drug - PBT2 - are to begin next month.
The breakthrough was made by a team at the Mental Health Research Institute of Victoria. The drug stops the build-up of amyloid, a protein which is widely accepted to be a major cause of Alzheimer's.
"This is a major breakthrough. Though much depends on the next phase of human clinical trials...early results indicate this drug offers hope to people with Alzheimer's disease", said Prof George Fink, director of the institute.
Early clinical tests involving animals indicate that the drug is fast-acting and is capable of suppressing the impairment of memory function that arises as a result of the disease.
According to Prof Fink, PBT2 could prevent Alzheimer's from developing or delay the onset of the disease for many years.
He added that pending further trials, the drug could be on the market within four years.
Wouldn't this be a great thing?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment